Behavioral modification represents the starting point for obesity prevention and management
Being prepared for whats to come and when to consult a doctor can make a big difference, too
The Triple Agonist Explained Retatrutide is a once-weekly injectable peptide developed by Eli Lilly
While these medicationsincluding semaglutide (Ozempic, Wegovy, Rybelsus) and liraglutide (Victoza, Saxenda)are FDA-approved only for metabolic conditions, emerging research explores whether their anti-inflammatory properties and effects on brain glucose metabolism might slow cognitive decline
These injections can also decrease the likelihood of gallstone formation and bolster the bodys natural defenses, increasing resistance to various diseases
Front Neurol 10:583 Perry TL, Berry K, Hansen S, Diamond S, Mok C (1971) Regional distribution of amino acids in human brain obtained at autopsy